Results 101 to 110 of about 4,064 (194)
Interferon Gamma Release Assays in active Tuberculosis: new medical insights
Since first presentation, Interferon γ Release Assays (IGRAs) have had basic and wide application to LTBI, in accordance with international consensus and CDC recommendations, leaving their use in active TB to the field of study and research.We reviewed ...
Sandro Pierdomenico +4 more
doaj +1 more source
Etanercept in the treatment of plaque psoriasis [PDF]
Thao U Nguyen, John KooDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, San Francisco, California, USAAbstract: Etanercept is approved for the treatment of moderate to severe plaque psoriasis at a ...
Thao U Nguyen, John Koo
core +1 more source
Latent tuberculosis infection screening and treatment in HIV: insights from evaluation of UK practice [PDF]
Latent TB infection (LTBI) screening and treatment in HIV-positive individuals in the UK is advocated by the British HIV Association (BHIVA) and National Institute for Health and Care Excellence (NICE), although each recommends differing strategies.
Lipman, MC +6 more
core
This preliminary study compares VIDAS TB-IGRA (bioMérieux, Marcy-l'Etoile, France) with the established QuantiFERON-TB Gold Plus (QFT-Plus) (Qiagen, Hilden, Germany) to evaluate diagnostic performance for the diagnosis of individuals infected with ...
Potiandi Serge Diagbouga +25 more
doaj +1 more source
BACKGROUND:Although QuantiFERON-TB Gold Plus (QFT-Plus), a new interferon-gamma release assay, has shown good performance in adults, little data is available in children. METHODS:De-identified data from TB-suspected patients age
Duc T Nguyen +11 more
doaj +1 more source
Background: The coexistence of HIV infection and latent tuberculosis infection (LTBI) presents a significant public health concern due to the increased risk of tuberculosis (TB) reactivation and progression to active disease.
Luca Pipitò +14 more
doaj +1 more source
Introduction: Contacts of tuberculosis (TB) patients have an increased risk of latent TB infection (LTBI). Currently, it is diagnosed using one of the two methods: Tuberculin skin test (TST) or QuantiFERON-TB Gold Plus.
Braja Sundar Barik +7 more
doaj +1 more source
AbstractPerformance of interferon-γ (IFN-γ) release assays still needs to be improved. The data on the performance of QuantiFERON-TB Gold Plus (QFT-Plus), a new-generation of QFT assay are limited. This study evaluated the diagnostic performance of QFT-Plus, and compared to that of QuantiFERON-TB Gold In-Tube (QFT-GIT).
Lina Yi +14 more
openaire +2 more sources
Современные возможности диагностики туберкулеза легких [PDF]
ТУБЕРКУЛЕЗ ЛЕГКИХ /ДИАГНМЕТОДЫ ИССЛЕДОВАНИЯБАКТЕРИОСКОПИЧЕСКИЙ МЕТОД ИССЛЕДОВАНИЯБАКТЕРИОЛОГИЧЕСКИЙ МЕТОД ИССЛЕДОВАНИЯГИСТОЛОГИЧЕСКИЕ ...
Будрицкий, А. М. +1 more
core
UEG Week 2025 Poster Presentations
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley +1 more source

